REGENXBIO, Inc. (RGNX)
8.46
+0.65
(+8.32%)
USD |
NASDAQ |
Mar 25, 16:00
8.12
-0.34
(-4.02%)
Pre-Market: 08:05
REGENXBIO Free Cash Flow : -126.38M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | -332.39M |
| AbbVie, Inc. | 17.82B |
| Krystal Biotech, Inc. | 188.91M |
| Replimune Group, Inc. | -283.27M |
| Ocugen, Inc. | -57.15M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -52.29M |
| Cash from Investing (Quarterly) | 37.54M |
| Cash from Financing (Quarterly) | -9.584M |
| Free Cash Flow Per Share (Quarterly) | -1.020 |
| Free Cash Flow to Equity (Quarterly) | -45.18M |
| Free Cash Flow to Firm (Quarterly) | -40.52M |
| Free Cash Flow Yield | -28.96% |